SCHEMBL14819947

SCHEMBL14819947

C[SiH2]CCOCn1c(C)nc2cc([N+](=O)[O-])c(Oc3ccc(CC(=O)O)cc3Cl)cc21

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 2/20 0.38
PPARA Q07869 2/20 0.38
PPARG P37231 1/20 0.37
DCTPP1 Q9H773 4/20 0.34
ALDH1A1 P00352 3/20 0.33
PTGDR Q13258 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
TTR P02766 1/20 0.32
FFAR1 O14842 1/20 0.32
NPC1 O15118 1/20 0.32
JAK2 O60674 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HKDC1 Q2TB90 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3641599 0.90 PPARD (0.39) PPARDPPARAPPARGDCTPP1ALDH1A1
SCHEMBL2003153 0.90 PPARD (0.39) PPARDPPARAPPARGDCTPP1ALDH1A1
SCHEMBL2008340 0.82 DCTPP1 (0.35) PPARDPPARAPPARGDCTPP1ALDH1A1
SCHEMBL14819929 0.79 ALDH1A1 (0.34) PPARGDCTPP1ALDH1A1MEN1KMT2A
SCHEMBL14819909 0.75 PPARD (0.40) PPARDPPARAPPARGPTGDRPTGDR2
SCHEMBL2002775 0.69 DCTPP1 (0.35) PPARGDCTPP1ALDH1A1MEN1KMT2A
SCHEMBL12570878 0.68 DCTPP1 (0.34) PPARGDCTPP1ALDH1A1MEN1KMT2A
SCHEMBL2006729 0.68 PDE7A (0.47) PPARDPPARAALDH1A1PTGDRPTGDR2
SCHEMBL14819904 0.67 GFER (0.39) ALDH1A1TTRNPC1HTTRAB9A
SCHEMBL2003571 0.65 PPARD (0.40) PPARDPPARAPPARGALDH1A1PTGDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2164828-B1 COMPOUNDS AS CRTH2 AND/OR PGD2 RECEPTORS MODULATORS AND THEIR USE FOR TREATING ASTHMA AND ALLERGIC INFLAMMATION AMGEN INC (US) 2013-03-27 EP disclosed